<scp>COVID</scp> ‐19 and plasma cells: Is there long‐lived protection?*-Reference-Cited by-同舟云学术

COVID ‐19 and plasma cells: Is there long‐lived protection?*

Published:2022-07-08 Issue:1 Volume:309 Page:40-63
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:Immunological Reviews

Author:

Nguyen Doan C.¹^ORCID,Lamothe Pedro A.¹^ORCID,Woodruff Matthew C.²³⁴^ORCID,Saini Ankur S.²³⁴^ORCID,Faliti Caterina E.²⁴^ORCID,Sanz Ignacio²³⁴^ORCID,Lee Frances Eun‐Hyung¹⁴^ORCID

Affiliation:

1. Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine Emory University Atlanta Georgia USA

2. Division of Rheumatology, Department of Medicine Emory University Atlanta Georgia USA

3. Emory Autoimmunity Center of Excellence Emory University Atlanta Georgia USA

4. Lowance Center for Human Immunology Emory University Atlanta Georgia USA

Funder

Bill and Melinda Gates Foundation

National Institutes of Health

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imr.13115

Reference356 articles.

1. Effect of COVID‐19 on the organs;Jain U;Cureus,2020

2. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection

3. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors

4. Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19

5. MobarakiPD WangC FloridiA FloridiA ZaidiAK.Long‐Term Persistence of IgG Antibodies in recovered COVID‐19 individuals at 18 months and the impact of two‐dose BNT162b2 (Pfizer‐BioNTech) mRNA vaccination on the antibody response.2022.https://www.medrxiv.org/content/10.1101/2022.01.18.22269349v1. Accessed February 27 2022.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling of Throbbing Invasive and Epidemic Processes Based on Biophysical Adaptation Hybrid Structures;Technical Physics;2024-09-13

2. Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity;Journal of Allergy and Clinical Immunology;2024-08

3. Boosting immunity to protect from tickborne Lyme disease;The Lancet Infectious Diseases;2024-07

4. Temporal dynamics and genomic programming of plasma cell fates;Nature Immunology;2024-05-02

5. Exploring new perspectives in immunology;Cell;2024-04